Shares of Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) rose sharply in today’s pre-market trading after the company agreed to be acquired by AstraZeneca for around $2 billion in cash.
As part of the ongoing collaboration with Vayu Aerospace, ParaZero's safety systems will be integrated into Vayu’s fleet of G-1MKII, G-1MKIII, US-1-MKII and US-2 delivery drones to be used as part...
The tech industry has been facing headwinds with year-long interest rate hikes, waves of job cuts, and trouble in the banking sector. Given the economic uncertainties ahead, I think fundamentally...
New York , June 04, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has…
Point Roberts, WA and Delta, BC - April 6, 2021 (Investorideas.com Newswire) - Investorideas.com, a global news source and leading retail investor and trader re...
New York, March 03, 2021 (GLOBE NEWSWIRE) -- - Medexus Pharmaceuticals Inc (CVE:MDP) shares climb as Canaccord Genuity upgrades rating to Buy from Hold ...
New York, Feb. 12, 2021 (GLOBE NEWSWIRE) -- - Alpine 4 Technologies Ltd (OTCQB:ALPP) enters definitive agreements for registered direct offering for gross ...